Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2010
12/29/2010CA2765815A1 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
12/28/2010USRE42012 Compositions and methods for enhancing receptor-mediated cellular internalization
12/28/2010US7858771 Chemically modified short interfering nucleic acid molecule for use in treatment of respiratory and pulmonary disease
12/28/2010US7858766 Nucleotide sequences coding HEV (hemorrhagic enteritis virus) or EDS (egg drop syndrome virus) capsid proteins for use in vaccinating domestic birds against pathogenic adenoviral infection
12/28/2010US7858754 Nel-related protein type 1 antibody
12/28/2010US7858750 Antibodies to tumor associated proteins
12/28/2010US7858625 Conjugates and compositions for cellular delivery
12/28/2010US7858592 inhibition of p53 transcription by interfering with the activity of a p53 promoter using inhibitory double-stranded RNAs; use of these inhibitory RNAs in the treatment of cancers
12/28/2010US7858588 Oligodeoxynucleic acid modified with (thio)phosphate
12/28/2010US7858577 Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2
12/28/2010US7858368 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars
12/28/2010US7858367 includes a deleted adenovirus vector genome having the adenovirus 5' and 3' cis-elements for viral replication and encapsidation and a recombinant adeno-associated virus (AAV) vector genome flanked by the adenovirus vector genome sequences; for gene therapy
12/28/2010US7858346 Regeneration and neogenesis of retinal visual cell-expressing Otx2 protein
12/28/2010US7858322 Method of determining inhibition of binding to TRPM7 protein
12/28/2010US7858312 Method of treating bladder and lower urinary tract syndromes
12/28/2010US7858094 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response
12/28/2010US7858086 Biopolymer mixture for use in diagnosis, prevention and treatment of acute myeloid leukemia
12/28/2010US7858083 Recombinant viral vector comprising antitumor agents for use in targeted tissue therapy; gene therapy; Replication-competent adenoviral vectors which selectively replicate in cancer cells
12/23/2010WO2010148203A2 Producer cells for replication competent retroviral vectors
12/23/2010WO2010148065A2 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
12/23/2010WO2010148050A2 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
12/23/2010WO2010147655A2 Compositions and methods relating to nucleic acid delivery vehicles
12/23/2010WO2010146055A1 Antagonists of beta-catenin for preventing and/or treating neurodegenerative disorders
12/23/2010US20100325746 Methods and sequences to suppress primate huntington gene expression in vivo
12/23/2010US20100325743 Marks as modifiers of the p53 pathway and methods of use
12/23/2010US20100324277 Oligomeric compounds comprising 4'-thionucleosides for use in gene modulation
12/23/2010US20100324126 Syn3 compositions and methods
12/23/2010US20100324124 Compositions and methods relating to DNA-based particles
12/23/2010US20100324122 Modulation of sglt2 expression
12/23/2010US20100324121 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/23/2010US20100323969 Compounds Binding to P-Selectin
12/23/2010US20100323922 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)
12/23/2010US20100322955 Virulence genes, proteins, and their use
12/23/2010US20100322911 Use of microwave irradiation for delivery of macromolecules
12/23/2010CA2765700A1 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
12/23/2010CA2765509A1 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
12/23/2010CA2764107A1 Producer cells for replication competent retroviral vectors
12/22/2010EP2264178A1 Vaccinia virus host range genes to increase the titer of Avipoxviruses
12/22/2010EP2264173A2 Use of a double-stranded ribonucleic acid for targeted inhibition of the expression of a given target gene
12/22/2010EP2264172A1 Oligomeric compounds for the modulation of HIF-1alpha expression
12/22/2010EP2264170A1 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
12/22/2010EP2264167A1 Double-stranded lipid-modified rna having high rna interference effect
12/22/2010EP2264146A1 Islet cells from human embryonic stem cells
12/22/2010EP2264073A1 Endothelial cell specific antibodies and uses thereof
12/22/2010EP2264072A1 Enhancement of antibody-mediated cytotoxicity.
12/22/2010EP2264059A1 Polypeptides, cDNAs encoding the same and utilization thereof
12/22/2010EP2264050A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263709A1 Medical device having hydration inhibitor
12/22/2010EP2263698A1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
12/22/2010EP2263690A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263689A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2262899A1 Method of treating genetic disorders
12/22/2010EP2262541A1 C2orf18 as target gene for cancer therapy and diagnosis
12/22/2010EP1799836B1 Improved adenoviral vectors and uses thereof
12/22/2010EP1541674B1 Primary cultured adipocytes for gene therapy
12/22/2010EP1135496B1 Ucp5
12/22/2010CN101923095A Identification and application of breast cancer suppressor protein
12/22/2010CN101921805A Plasmid-mediated telomerase RNA gene interference constructing body and constructing method thereof
12/22/2010CN101921787A schistosoma japonica adenosine deaminase gene and coding protein and application thereof
12/22/2010CN101921783A Schistosoma japonica L-lactic dehydrogenase gene, encoding protein and application thereof
12/22/2010CN101921782A Schistosoma japonica arginyl transport RNA enzyme gene, encoding protein and application thereof
12/22/2010CN101921769A Recombinant adenovirus, preparation method and application thereof
12/22/2010CN101921768A Schistosoma japonica 14-3-3 protein gene, coded protein thereof and application thereof
12/22/2010CN101921767A Schistosoma japonica MF3 protein gene, and coding protein and application thereof
12/22/2010CN101921763A siRNA capable of inhibiting expression of PAR-1 gene and application thereof
12/22/2010CN101921732A A virus causing respiratory tract illness in susceptible mammals
12/22/2010CN101921292A Novel siRNA chemical modification monomer, preparation method thereof and use thereof
12/22/2010CN101920022A Specific anti-virus antisense nucleic acid medicament for avian influenza virus
12/22/2010CN101920021A Immune-enhanced hepatitis B therapeutic multivalent vaccine and preparation method thereof
12/22/2010CN101920020A New application of human MED19 genes in tumor therapy
12/22/2010CN101920011A Recombination attenuated salmonella typhimurium carrier vaccine of expression IBDV (Infectious Bursal Disease Virus) immunogenic gene and preparation method thereof
12/22/2010CN101920009A Vaccine for preventing and curing tumor
12/22/2010CN101920006A Cyclin Y and use thereof
12/22/2010CN101319215B Human tumour specific Ki67 gene promotor
12/22/2010CN101095951B Therapeutic HBV DNA vaccines, method for preparing the same and application thereof
12/22/2010CN101070547B Recombined protein carrier PEA II-HphA of actively carrying exogenic gene, its preparing method and use
12/21/2010US7855323 Antisense agents; gene expression inhibition; transcription
12/21/2010US7855278 antibodies which induces the death of a cell that expresses Stra6 polypeptide; used to prevent or slow down (lessen) the development, growth, or spread of tumor characterized by the overexpression of a PRO10282 polypeptide; chemotherapy
12/21/2010US7855184 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells and methods of treating ophthalmic and dermatological diseases
12/21/2010US7855182 Using glypican 5 antagonist as therapeutic in treatment of mammary gland cell proliferative disorders
12/21/2010US7855178 antagonizing the function of vascular endothelial growth factor (VEGF) receptors, platelet derived growth factor (PDGF) receptors and other receptors; for inhibition of aberrant angiogenesis and lymphangiogenesis, and inhibition of other effects of members of the PDGF/VEGF family of growth factors
12/21/2010US7855075 Methods of controlling proliferation and differentiation of stem and progenitor cells
12/21/2010US7855058 Human cyclin-dependent kinase (hPNQALRE)
12/21/2010US7855056 Antibody against tumor specific antigen as target
12/21/2010US7854933 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
12/21/2010US7854927 reducing a symptom of psoriasis by administering a composition comprising Bacillus coagulans bacteria in an amount effective to reduce serum TNF- alpha levels; skin disorders
12/21/2010US7854923 A biocompatible, biodegradable composition that does not use animal products comprises a hydrogel produced by mixing a solution comprising an acrylated chitosan with a solution of oxidized dextran; surgical procedures, such as in closing a suture line; cuts, tears, holes, bone breaks and other injury
12/21/2010CA2387182C Lentiviral vectors for the preparation of immunotherapeutical compositions
12/21/2010CA2307316C Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies
12/21/2010CA2267069C Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
12/21/2010CA2260273C Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
12/16/2010WO2010144908A2 Mammalian genes involved in tularemia and other infections
12/16/2010WO2010144698A2 Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells
12/16/2010WO2010144611A2 Antivirals that target transporters, carriers, and ion channels
12/16/2010WO2010144336A2 Methods for treating chronic kidney disease
12/16/2010WO2010144324A2 Use of stamp related molecules in the diagnosis and inhibition of ovarian cancer cells
12/16/2010WO2010144295A1 Aptamer-targeted costimulatory ligand aptamer
12/16/2010WO2010142017A1 Administration of interferon for prophylaxis against or treatment of pathogenic infection
12/16/2010WO2010120511A3 Method of treating respiratory disorders
12/16/2010WO2010118832A3 Inhibition of the liver enriched protein foxa2 for the treatment of colorectal liver metastases